Martyn Coombs
Plus aucun poste en cours
Profil
Martyn Coombs served as the President of PerkinElmer Japan Co. Ltd.
and as the President of Jubilant DraxImage, Inc. from 2012 to 2016.
He was also the Chief Executive Officer and Director of ImaginAb, Inc. from 2017 to 2019, and the Chief Executive Officer and Executive Director of BioSeek Plc from 2010 to 2011.
Prior to that, he served as the President and Executive Director of Amersham KK and the Executive Vice President of Nihon Medi-Physics Co., Ltd.
Coombs received his undergraduate degree and MBA from Warwick Business School.
Anciens postes connus de Martyn Coombs
| Sociétés | Poste | Fin |
|---|---|---|
ImaginAb, Inc.
 ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Directeur Général | 26/02/2019 |
Jubilant Draximage, Inc.
 Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | President | 01/03/2016 |
| BIOSEEK PLC | President | 29/07/2011 |
| Amersham KK | President | - |
| PerkinElmer Japan Co. Ltd. | President | - |
Formation de Martyn Coombs
| Warwick Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
BioSeek Plc
 BioSeek Plc Miscellaneous Commercial ServicesCommercial Services BioSeek Plc provides human tissue-based research services for the pharmaceutical industry. It focuses on applying human primary cell assays and predictive disease models to the discovery and development of human therapeutics and safer chemicals. The company was founded by Eugene Butcher in March 1996 and is headquartered in London, the United Kingdom. | Commercial Services |
Nihon Medi-Physics Co., Ltd.
 Nihon Medi-Physics Co., Ltd. Pharmaceuticals: MajorHealth Technology Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura. | Health Technology |
| PerkinElmer Japan Co. Ltd. | |
| Amersham KK | |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Health Technology |
Jubilant Draximage, Inc.
Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | Health Technology |